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The selective and neuronal activity-dependent degradation of synaptic proteins appears
to be crucial for long-term synaptic plasticity. One such protein is activity-regulated
cytoskeleton-associated protein (Arc), which regulates the synaptic content of α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR), excitatory synapse
strength and dendritic spine morphology. The levels of Arc protein are tightly regulated,
and its removal occurs via proteasome-mediated degradation that requires prior
ubiquitination. Glycogen synthase kinases α and β (GSK3α, GSKβ; collectively named
GSK3α/β) are serine-threonine kinases with abundant expression in the central nervous
system. Both GSK3 isozymes are tonically active under basal conditions, but their
activity is regulated by intra- and extracellular factors, intimately involved in neuronal
activity. Similar to Arc, GSK3α and GSK3β contribute to synaptic plasticity and the
structural plasticity of dendritic spines. The present study identified Arc as a GSK3α/β
substrate and showed that GSKβ promotes Arc degradation under conditions that
induce de novo Arc synthesis. We also found that GSK3α/β inhibition potentiated spine
head thinning that was caused by the prolonged stimulation of N-methyl-D-aspartate
receptors (NMDAR). Furthermore, overexpression of Arc mutants that were resistant
to GSK3β-mediated phosphorylation or ubiquitination resulted in a stronger reduction
of dendritic spine width than wildtype Arc overexpression. Thus, GSK3β terminates Arc
expression and limits its effect on dendritic spine morphology. Taken together, the results
identify GSK3α/β-catalyzed Arc phosphorylation and degradation as a novel mechanism
for controlling the duration of Arc expression and function.
Keywords: Arc/Arg3.1, GSK3, proteasomal degradation, phosphorylation, dendritic spines, neuronal activity,
NMDA
INTRODUCTION
Activity-regulated cytoskeleton-associated protein (Arc; also known as Arg3.1) is a ‘‘short-lived’’
protein that is expressed in a neuronal activity-dependent manner. Arc emerged as a crucial
regulator of various forms of synaptic plasticity (Bramham et al., 2010; Korb and Finkbeiner, 2011;
Shepherd and Bear, 2011). Arc is required for the formation of long-term memory (Guzowski
et al., 2000; Plath et al., 2006; Ploski et al., 2008) and maintenance of neuronal circuit homeostasis
(Gao et al., 2010; Peebles et al., 2010). Arc appears to have multiple distinct roles in neuronal
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plasticity. First, the ability of Arc to organize the actin
cytoskeleton was shown to be necessary for long-term
potentiation (LTP) consolidation in hippocampal neurons
(Messaoudi et al., 2007). Arc was also shown to regulate
the strength of excitatory synapses through interactions
with endocytic machinery elements, such as dynamin 2 and
endophilins 2/3 (Chowdhury et al., 2006), stargazin (Zhang
et al., 2015), and clathrin adaptor protein 2 (DaSilva et al., 2016),
and promote endocytosis of the GluA1 subunit of α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors
(AMPARs). AMPAR endocytosis is required for homeostatic
synaptic scaling (Shepherd et al., 2006) and metabotropic
glutamate receptor (mGluR)-dependent long-term depression
(LTD; Park et al., 2008; Waung et al., 2008; Jakkamsetti et al.,
2013). Moreover, the Arc-dependent removal of AMPARs from
the synapse influences dendritic spine morphology (Peebles
et al., 2010). In addition to immediate actions of Arc at the
synapse, Arc accumulates within the cell nucleus upon the
massive induction of Arc synthesis and downregulates GluA1
transcription (Korb et al., 2013).
Arc expression is induced by various stimuli, including
glutamate (Lyford et al., 1995; Rao et al., 2006; Panja et al., 2009).
The stimulation of glutamate N-methyl-D-aspartate receptors
(NMDARs) is crucial for the induction of Arc expression
during LTP at dentate gyrus synapses (Lyford et al., 1995;
Panja et al., 2009). The increase in Arc in response to the
γ-aminobutyric acid receptor (GABAR) antagonists bicuculline
and picrotoxin requires NMDARs (Rao et al., 2006; Bateup
et al., 2013). Similar to many other products of immediate early
genes, Arc is both rapidly accumulated and quickly degraded
by the ubiquitin-proteasome system (Rao et al., 2006; Greer
et al., 2010; Soulé et al., 2012; Bateup et al., 2013; Mabb
et al., 2014). To date, two E3 ubiquitin ligases, Triad3A and
Ube3a, have been shown to tag Arc for subsequent proteasomal
degradation (Greer et al., 2010; Mabb et al., 2014). Several
proteins that are destined for proteasomal degradation need to
be phosphorylated prior to tagging by E3 ubiquitin ligases, but
the phosphorylation of Arc has not been investigated in this
context.
Glycogen synthase kinases α and β (GSK3α and GSK3β;
further collectively named GSK3α/β) are serine-threonine
kinases with abundant expression in the central nervous
system. Both are tonically active under basal conditions, but
their activity changes in response to neurotrophic factors and
neurotransmitters (Cole, 2012). GSK3α/β control both neuronal
development and learning and memory processes (Salcedo-
Tello et al., 2011; Cole, 2012), the latter of which occurs
through an effect that is exerted by GSK3α/β on synaptic
plasticity and the structural plasticity of dendritic spines.
GSK3α/β activity is necessary for NMDAR-dependent LTD
expression in hippocampal synapses (Peineau et al., 2007, 2009)
and the maintenance of dendritic spine morphology under
basal conditions (Ochs et al., 2015; Kondratiuk et al., 2017)
or dendritic spine rearrangements upon chemical NMDAR-
dependent LTD induction (Cymerman et al., 2015). GSK3α/β
phosphorylate structural proteins that are crucial for synaptic
plasticity, e.g., PSD-95 (Nelson et al., 2013), control actin
dynamics within dendritic spines (Cymerman et al., 2015),
regulate endocytosis at presynaptic (Clayton et al., 2010) and
postsynaptic sites (Chen et al., 2007; Wei et al., 2010), and control
the activity of the secreted protease matrix metalloproteinase-9
(Kondratiuk et al., 2017). Notably, in non-neuronal cells,
many GSK3α/β substrates, upon their phosphorylation, undergo
ubiquitination and proteasome-dependent degradation (Xu
et al., 2009). To date, the most extensively studied protein
that is degraded in a GSK3α/β-dependent manner is β-catenin.
GSK3β/β-catenin pathway was shown to regulate excitatory
transmission in hippocampal neurons under basal conditions
in vivo (Ochs et al., 2015) and upon LTP induction in
hippocampal slices (Chen et al., 2006). However, with the
exception of β-catenin, the effect of the GSK3α/β-dependent
degradation of synaptic proteins has not been thoroughly
investigated.
In the present study, we identified Arc as a neuronal activity-
related GSK3α/β substrate. Arc that was synthesized in response
to extended NMDA treatment was subjected to phosphorylation
by GSK3α/β and GSK3α/β-dependent degradation. At the
same time prolonged NMDAR stimulation caused reduction
of dendritic spine width. GSK3α/β inhibition enhanced the
effect of NMDA on dendritic spine morphology, coinciding
with an increase in Arc protein stability and expression.
The overexpression of more stable, unphosphorylatable or
ubiquitination-resistant mutants of Arc reproduced the effect
of concomitant NMDAR stimulation and GSK3α/β inhibition
on spine morphology, indicating that the GSK3α/β-dependent
regulation of Arc turnover contributes to the structural plasticity
of dendritic spines.
MATERIALS AND METHODS
Animals
All of the procedures for harvesting animal tissue were approved
by the First Ethical Committee (Warsaw, Poland; protocols no.
188/2011, 198/2011, 92/2015) and performed in accordance with
the First Ethical Committee guidelines.
Antibodies
The primary antibodies used in the study are listed in Table 1.
Anti-phospho S170/T175 Arc antibody was developed by
immunizing rabbits with KLH-conjugated phosphopeptide
(GYDYTVS∗PYAIT∗P), and then cross-affinity purified using
corresponding phosphorylated and non-phosphorylated
peptides (Eurogentec, Liege, Belgium). Horseradish peroxidase
(HRP)-conjugated secondary antibodies that were used for
immunoblotting followed by enhanced chemiluminescence
(ECL) detection were obtained from Jackson ImmunoResearch
Laboratories (1:10,000; West Grove, PA, USA). IRDye 800CW-
conjugated and IRDye 680LT-conjugated secondary antibodies
for quantitative Western blot were obtained from LI-COR
Biosciences (1:10,000; Lincoln, NE, USA). Alexa Fluor-
conjugated secondary antibodies used for immunofluorescent
staining were obtained from Thermo Fisher Scientific (1:200;
Waltham, MA, USA).
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TABLE 1 | Antibodies.
Primary antibody (clone) Manufacturer, catalog no. Application, dilution
Rabbit anti-Arc (polyclonal) Synaptic Systems (Goettingen, Germany), #156003 Western blot, 1:2000
Immunocytochemistry, 1:300
Mouse anti-β-catenin (14/β-catenin) BD Biosciences (Franklin Lakes, NJ, USA), #610154 Immunocytochemistry, 1:300
Mouse anti-GSK3α/β (21 A) Thermo Fisher Scientific (Waltham, MA, USA), #44-610 Western blot, 1:2000
Mouse anti-α-tubulin (B 5-1-2) Sigma-Aldrich (St. Louis, MO, USA), #T5168 Western blot, 1:20,000
Mouse anti-FLAG (M2) Sigma-Aldrich, #F3165 Western blot, 1:1000
Rabbit anti-HA (C29F4) Cell Signaling Technology (Danvers, MA, USA), #3724 Western blot, 1:1000
Rat anti-HA (3F10) Sigma-Aldrich/Roche, #11867423001 Immunocytochemistry, 1:200
Mouse anti-GFP (C 163) Thermo Fisher Scientific, #33-2600 Immunocytochemistry, 1:500
Drugs
CHIR 98014 (CH98) was obtained from Axon Med Chem
(Groningen, The Netherlands). BIO, anisomycin, cycloheximide,
and NMDA were obtained from Sigma-Aldrich (St. Louis,
MO, USA). MG-132 was obtained from Tocris Bioscience
(Bristol, UK). NMDA and cycloheximide were dissolved in
Neurobasal medium (Thermo Fisher Scientific) and methanol,
respectively. The other drugs used in the study were dissolved in
dimethylsulfoxide (DMSO).
DNA Constructs
The following plasmids were described previously: β-actin-
16pl (Kaech et al., 1996), pSuper (Brummelkamp, 2002),
β-actin-GFP (Jaworski et al., 2005), β-actin-mCherry (de Vrij
et al., 2008), BirA (de Boer et al., 2003), pEGFPC2-BIO (de
Boer et al., 2003), BIO-βGal (Swiech et al., 2011), pGL4.11-
SARE-ArcMin-luc2P (Kawashima et al., 2009), pUltra-Chili (gift
from Dr. M. Moore, Addgene plasmid no. 48687), pCMV-
VSV-G (Stewart et al., 2003), RSV-Rev (Dull et al., 1998),
pMDLg/pRRE (Dull et al., 1998), HA GSK3β K85A pcDNA3,
HA GSK3β S9A pcDNA3, and GSK3α pMT2 (all gifts from
Dr. J. Woodget, Addgene plasmid no. 14755, 14754 and
15896, respectively). Genomic human and mouse Arc (IMAGE
clones IRATp970A1095D and 3498057) were purchased from
SourceBioScience (Nottingham, UK). GSK3α and β open reading
frames were amplified by polymerase chain reaction (PCR)
based on Addgene plasmid DNA and inserted into KpnI
and NotI sites of a modified pcDNA3 FLAG vector, yielding
GSK3α and GSK3β constructs that were FLAG-tagged on
the C-terminus. A kinase dead GSK3α K148A and GSK3α
S21A mutants were created by site-directed mutagenesis
using Pfu Turbo DNA polymerase (Agilent, Santa Clara,
CA, USA), based on wildtype GSK3α. To obtain efficient
expression in neurons, FLAG GSK3β S9A was PCR-amplified
and subcloned into BspTI and XbaI sites of the β-actin-16pl
vector. pGEX Arc was generated by insertion of PCR-amplified
Arc ORF using rat brain cDNA and the High Fidelity PCR
enzyme mix (Thermo Fisher Scientific) into BamHI and
XhoI sites of pGEX vector obtained from GE Healthcare
Life Sciences (Buckinghamshire, UK). BIO-Arc constructs,
which allow the expression of N-terminally avi-tagged Arc
that is suitable for biotinylation, were generated by the
insertion of PCR-amplified rat or human Arc ORFs into
HindIII and EcoRI sites of modified pEGFPC2-BIO plasmid
after EGFP sequence excision. Avi-tag contructs used for
co-precipitation experiments were additionally HA-tagged on
the N-terminus. SARE-Arc and SARE-mCherry constructs
(Figure 3E) were generated in several steps. First, the Arc
gene enhancer SARE and minimal Arc promoter (ArcMin)
were PCR-amplified based on the pGL4.11-SARE-ArcMin-
luc2P plasmid and inserted into XhoI and NotI sites of the
pBluescript II KS (+) vector (Agilent), simultaneously generating
a new SalI restriction site. Second, PCR-amplified genomic
mouse Arc and mCherry sequences were PCR-cloned and
ligated into SalI and NotI sites of a pBluescript plasmid
that carried the SARE-ArcMin sequence. Third, BsrGI and
BamHI sites were introduced by PCR into the genomic
Arc sequence before the start codon. An HA oligonucleotide
that was designed to have sticky ends that were compatible
with BsrGI- and BamHI-generated ends was inserted, yielding
an N-terminally tagged Arc construct. Lentiviral SARE-Arc
vectors were generated by PCR cloning of the SARE-ArcMin-
HA-Arc cassette, and insertion into PacI and NheI sites of
pUltra-Chili remained after excision of the hUbC promoter
and dTomato sequence. S170A/T175A, T368A/T380A, and
S170A/T175A/T368A/T380A (4A) mutants were generated
by PCR-based site-directed mutagenesis using BIO-Arc and
SARE-Arc plasmids as a template. The same method was used
to create the K136R mutant of SARE-Arc. To knockdown Arc
expression, oligonucleotides encoding shRNAs targeting mouse
Arc mRNA (later referred to as shArc) were inserted into
BglII and HindIII sites of pSuper. The following sequences
in Arc mRNA were targeted: ACCCAATGTGATCCTGCAG
(Greer et al., 2010), GCGCTGGAAGAAGTCCATCAA and
GGGTGGCTCTGAAGAATAT (both designed with the use of
Whitehead Institute for Biomedical Research online tool)1.
Dissociated Neuronal Culture Preparation,
Transfection, Lentiviral Transduction and
Pharmacological Treatment
Dissociated hippocampal or cortical primary neuronal cultures
were prepared from embryonic day 17 FVB mouse embryos.
They were cultured as previously described (Cymerman et al.,
2015) and used for experiments on day in vitro (DIV) 12–16.
Hippocampal neurons were transfected on DIV 12–13 using
Lipofectamine 2000 (Thermo Fisher Scientific) as described
1http://sirna.wi.mit.edu/
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previously (Cymerman et al., 2015) and treated 48 h post
transfection when shRNA was used. All other transfections were
performed on DIV 13–14 and cells were treated 20 h later.
To transduce cortical neurons with lentiviral vectors, cells on
DIV 14–15 were incubated with lentiviral particles for 5 h
followed by two washes in Neurobasal medium. Transduced
neurons were used for further experiments 16 h later. NMDAR
stimulation with 10 µM NMDA was performed in neuronal
culture medium and lasted 4 h, as previously described (Bloomer
et al., 2008). In experiments, where Arc mRNA expression was
measured, incubation with 10 µM NMDA was shortened to 2 h.
When applicable, cells were pretreated with vehicle (DMSO) or
GSK3α/β inhibitors for 1 h.
HEK293 and HEK293T Cell Line Cultures
HEK293 and HEK293T cells were purchased from ATCC
(Manassas, VA, USA) and cultured in Dulbecco’s Modified Eagle
Medium (DMEM) with 4500 mg/ml glucose supplemented with
10% fetal bovine serum (FBS) and penicillin-streptomycin (all
from Sigma-Aldrich).
Lentiviral Particle Production
To pack SARE-Arc DNA into lentiviral particles, HEK293T cells
were transfected with lentiviral SARE-Arc vectors and packaging
plasmids (pCMV-VSV-G, pRSV-Rev and pMDLg-pRRE) using
the calcium phosphate transfection method. Six hours later,
the transfection mix was removed. The cells were rinsed with
phosphate-buffered saline (PBS), 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4, and grown in
standard neuronal culture medium without glutamate for the
next 40 h. The culture medium that contained viral particles was
then centrifuged at 2000× g for 7 min at 4◦C. The supernatant
was aliquoted and stored at−80◦C.
RNA Isolation, Reverse Transcription and
Quantitative Polymerase Chain Reaction
RNA isolation and cDNA synthesis were performed as described
previously (Malik et al., 2013). Quantitative real-time PCR
(RT-qPCR) was run on a 7900HT real-time PCR thermal cycler
(Applied Biosystems, Foster City, CA, USA) with SYBR Green
PCR Master Mix (Thermo Fisher Scientific) and the PCR primers
that are listed in Table 2.
Protein Production in Bacteria and GST
Pulldown
GST-fused Arc or GST alone was expressed in the
BL21 CodonPlus strain of E. coli (Agilent) and purified using
glutathione Sepharose 4B (GE Healthcare, Chicago, IL, USA)
according to the manufacturer’s instructions. Beads were washed
TABLE 2 | RT-qPCR primers.
Gene Sequence References
Arc/Arg3.1 forward AGCCAGGAGAATGACACCAG Mateos et al. (2009)
Arc/Arg3.1 reverse GGCAGCTTCAGGAGAAGAGA
GAPDH forward CATCAAGAAGGTGGTGAAGCA Rao et al. (2006)
GAPDH reverse CTGTTGAAGTCACAGGAGACA
and incubated for 1 h with lysate from the rat hippocampal CA
region (1 mg/ml) prepared in lysis buffer (50 mM Tris-HCl
[pH 7.4], 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid,
0.5% NP-40 supplemented with 1 mM phenylmethanesulfonyl
fluoride [PMSF], and 1× Complete Protease Inhibitor Cocktail
[Sigma-Aldrich]). The beads were then washed with lysis buffer,
and bound proteins were eluted by boiling in Laemmli buffer.
GSK3α/β binding was detected using an anti-GSK3α/β antibody.
GST-fused proteins were visualized by the ‘‘stain-free’’ technique
(Bio-Rad, Hercules, CA, USA).
Protein Overexpression in HEK293 Cells
and Protein Purification
HEK293 cells were grown under standard conditions to 70%
confluence and transfected with BIO-Arc or BIO-βGal together
with BirA plasmid using jetPEI (Polyplus-transfection, Illkirch,
France). Forty-six hours later, the cells were treated with
the reversible GSK3α/β inhibitor CH98 (1 µM) for 2 h to
inhibit GSK3α/β-dependent protein phosphorylation within
cells, harvested by scraping in PBS with 100 mM NaF, and
centrifuged at 1000× g at 4◦C for 10 min. The cells were then
lysed in buffer that contained 20 mM Tris (pH 8.0), 150 mM
KCl, 1% Triton, and protease and phosphatase inhibitors (Sigma-
Aldrich) and centrifuged at 15,000× g for 10 min at 4◦C. The
supernatant was collected, loaded on streptavidin-coated beads
(Dynabeads M280, Thermo Fisher Scientific), and rotated for
3 h at 4◦C, followed by extensive washes in cell lysis buffer with
500 mM KCl and 2% Triton X-100. Finally, biotinylated protein-
containing beads were resuspended in appropriate buffer,
depending on the further application (i.e., avi-tag pulldown,
in vitro kinase assay, and MS).
Avi-tag Pulldown
Beads with captured Arc or β-Gal (prepared as described
above) were washed twice in pulldown buffer (20 mM HEPES
[pH 7.3], 150 mM KCl, 0.25% NP-40, and protease and
phosphatase inhibitors) and rotated with the homogenate
of the mouse hippocampus that was prepared in the same
buffer for 4 h at 4◦C, followed by four mild washes in
pulldown buffer and boiling in 2× Laemmli buffer. The level of
GSK3α/β that bound to biotinylated proteins was evaluated by
immunoblotting.
Avi-tag Co-Precipitation
HEK293 cells were co-transfected with BIO-Arc, BirA and
wildtype or inactive forms of GSK3α or GSK3β. Twenty hours
posttransfection, the growth medium was replaced with DMEM
that contained 1000 mg/ml glucose and 10% FBS for 4 h, followed
by cell lysis in avi-tag pulldown buffer and centrifugation at
15,000× g for 10 min at 4◦C. Arc protein complexes were
captured on streptavidin-coated beads, washed four times in the
same buffer, and denatured. Arc-GSK3α/β complexes were then
analyzed by Western blot.
Western Blot
Proteins that were denatured in Laemmli buffer were separated
by sodium dodecyl sulfate polyacrylamide gel electrophoresis
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(SDS-PAGE) and transferred to nitrocellulose membranes. The
membranes were blocked in 5% nonfat milk in TBS-T buffer
and incubated with primary antibody overnight at 4◦C. The
membranes were then washed and incubated with secondary
HRP-conjugated antibodies or LI-COR fluorescently labeled
secondary antibodies, followed by ECL detection or analysis with
the LI-COR Odyssey Imaging System (LI-COR Biosciences). For
the detection of biotinylated proteins, Western blot membranes
were incubated overnight with IRDye Streptavidin 800CW at
1:1000 dilution (LI-COR Biosciences) and analyzed with the
LI-COR Odyssey Imaging System.
In Vitro Kinase Assay and Autoradiography
Beads with captured Arc were prepared as described above,
rinsed twice in kinase assay buffer (50 mM HEPES [pH 7.3]
and 15 mM MgCl2), and incubated with or without recombinant
human GSK3α or GSK3β (2 ng/µl, Merck Millipore) in the
presence of 2.5 µCi of [γ-P33] ATP (Hartmann Analytic GmbH,
Braunschweig, Germany) and 100 µM cold ATP for 30 min at
30◦C. The beads were then washed twice with the buffer that was
used for HEK293 cell lysis and then boiled in 2× Laemmli buffer.
The samples were resolved by SDS-PAGE. The gel was stained
with Coomassie Brilliant Blue, dried, and autoradiographed.
The radioactive signal was detected using a Typhoon Trio+
Phosphorimager (GE Healthcare).
MS/MS Analysis of Protein Ubiquitination
To identify posttranslational modifications of Arc protein,
liquid chromatography coupled with MS was performed as
described previously (Graczyk et al., 2011; Zaremba-Czogalla
et al., 2011), with modifications. For the identification of
GSK3β-dependent ubiquitination, Arc protein that was
captured on streptavidin-coated beads was reduced with
5 mM Tris(2-carboxyethyl)phosphine (TCEP, RT, 1 h),
methylthiolated with 10 mM methyl metanethiosulfonate
(MMTS, RT, 10 min) to block free thiols, and digested
with 10 ng/µl trypsin (Promega, Fitchburg, WI, USA)
overnight at 37◦C. The peptide mixture was concentrated
and desalted on an RP-C18 pre-column (nanoACQUITY
Symmetry C18, Waters, Milford, MA, USA), and further
peptide separation was achieved using a nanoACQUITY
nano-Ultra Performance Liquid Chromatography (UPLC)
RP-C18 column (BEH130 C18 column, 75 µm inner diameter,
250 mm length, Waters) with an acetonitrile gradient (5%–35%
AcN for 45 min) in the presence of 0.05% formic acid at a flow
rate of 150 nl/min. The column outlet was directly coupled
to the electrospray ionization source of an Orbitrap Velos
type mass spectrometer (Thermo Fisher Scientific), working
in the regime of data dependent MS to MS/MS switch with
higher energy collisional dissociation (HCD) type of peptide
fragmentation. An electrospray voltage of 2 kV was used.
Raw data files were pre-processed using Mascot Distiller
2.4.2.0 software (MatrixScience). The peptide masses and
fragmentation spectra were matched to the Swiss-Prot database
(548586 sequences/195452300 residues) with a Rattus filter
(7937 sequences) using the Mascot search engine (Mascot
Daemon v. 2.4.0, Mascot Server v. 2.4.1, MatrixScience)
and the following search parameters: enzyme specificity set
to trypsin, protein mass left unrestricted, and mass values
as monoisotopic with one missed cleavage allowed. The
oxidation of methionine, the methyltiolation of cystein,
the phosphorylation of serine, threonine, and trypsin, and
ubiquitination were set as modifications. Peptides with a Mascot
score that exceeded the threshold value (corresponding to <1%
false positive rate, calculated by the Mascot procedure) were
considered to be positively identified.
MS/MS Analysis of Protein
Phosphorylation
To identify phosphorylated residues within the Arc sequence,
rat Arc protein was overexpressed in HEK293 cells, purified
as described above, denatured, and subjected to SDS-PAGE.
The gel was stained with Coomassie Brilliant Blue, and bands
that corresponded to Arc were excised. The samples were then
subjected to ‘‘in-gel digestion’’ with trypsin, during which the
proteins were reduced with 100 mM DTT (30 min at 56◦C),
alkylated with 0.5 M iodoacetamide (45 min in a darkroom
at room temperature), and digested with trypsin. The resulting
peptides were eluted from the gel with 0.1% trifluoroacetic
acid (TFA). To improve Arc protein digestion, the trypsin-
digested samples were acidified and additionally digested by
pepsin (Immobilized Pepsine, Thermo Fisher Scientific) for 1 h
at 24◦C. Digested peptides were mixed with loading buffer (80%
acetonitrile, 5% TFA, and 1 M phthalic acid) and incubated
with an equilibrated MagReSyn Ti-IMAC microsphere pellet
(ReSyn Biosciences, Edenvale, South Africa) for 20 min. The
supernatant was then removed, and microspheres with chelated
titanium ions were washed with loading buffer and next with
wash buffer (80% acetonitrile and 1% TFA). Phospho-peptides
were eluted with water that was alkalized with ammonia to
pH 10.5 and immediately acidified with 50% TFA after elution.
The obtained peptides were applied to an RP-C18 pre-column
as described above. The acquired raw data were processed
by the Mascot distiller, followed by a database search with
the Mascot program against the Users database. The search
parameters for precursor and product ion mass tolerance were
30 ppm and 0.1 Da, respectively, with no enzyme specificity,
fixed modifications through cysteine carbamidomethylation,
and the following variable modifications: methionine oxidation,
and serine, threonine, and tyrosine phosphorylation. Peptides
that were identified in the Mascot search as phosphorylated
were subjected to the confirmation procedure based on visual
inspection of the fragmentation spectra that corresponded to
the modified (and unmodified, when detected) peptide and
identification of a significant fraction of expected product ions.
Immunocytochemistry, Image Acquisition
and Analysis
For endogenous Arc detection, hippocampal neurons that were
grown on coverslips were fixed with methanol at −20◦C
for 2 min, followed by fixation in 4% paraformaldehyde
(PFA)/4% sucrose in PBS for 10 min at room temperature.
The fixed cells were then incubated with blocking solution
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(10% normal goat serum and 0.1% Triton X-100 in PBS)
for 1 h at 37◦C, incubated with rabbit anti-Arc antibody in
GDB buffer (0.2% gelatin, 0.8 M NaCl, 0.5% Triton X-100,
and 30 mM phosphate buffer, pH 7.4; Jaworski et al., 2005)
overnight at 4◦C, and incubated with secondary antibody
for 1 h at room temperature in the same buffer. For all
of the other stainings, the cells were fixed with PFA as
described above and incubated with appropriate antibody in
GDB. To evaluate protein expression, Z-stack images were
acquired with a Zeiss NLO710 confocal microscope at 40×
magnification and 512 × 512 pixel resolution, and each Z-stack
image was averaged twice. The microscope settings were kept
constant for the entire experiment. To reveal endogenous
Arc expression, single Z-stack images were compressed to
obtain the maximum intensity projection. To measure the
fluorescence intensity of HA-tagged Arc and mCherry in
single Z-stack images, MetaMorph image analysis software
(Molecular Devices, Sunnyvale, CA, USA) was used. The
HA fluorescence intensity that was measured from single
Z-stacks was then divided by the mCherry fluorescence intensity
from the same Z-stack. The obtained values were summed,
yielding HA-Arc expression that was normalized to mCherry
expression. To analyze dendritic protrusions properties, neurons
were co-transfected with β-actin-GFP, which allowed the
visualization of cell morphology. To enhance the GFP signal,
staining with anti-GFP antibody was performed. HA-tagged Arc
expression was detected as above, when appropriate. Images were
acquired with a Zeiss NLO800 Airyscan confocal microscope
and 63× objective. Confocal cell images were obtained at
1024 × 1024 pixel resolution. Each image was a z-series of
images, which were averaged twice per line. Z-stack images
were compressed to obtain maximum intensity projections.
The width of dendritic protrusions on secondary and tertiary
dendrites was measured using MetaMorph software. When
protrusion width was ≤0.4 µm, protrusion was classified as
filopodium. All other protrusions were classified as dendritic
spines and divided into three categories: spines without distinct
neck were classified as stubby, spines with neck and head
diameter equal or above medium spine width calculated for
all experiments (0.78 µm) were considered as mushroom
spines and spines with neck and head diameter <0.78 µm
were classified as thin ones. Finally, percentage of filopodia
and each class of dendritic spines on dendrite segment was
calculated.
Statistical Analysis
The data are expressed as mean ± standard error of the
mean (SEM). The statistical analysis was performed using Prism
5 software (GraphPad, La Jolla, CA, USA). When multiple
comparisons between experimental groups were performed
One-way ANOVA followed by Bonferroni post hoc test was used.
When only two groups (treatment vs. respective control) t-test
or Mann-Whitney test (for data lacking normal distribution)
was applied. In case when control = 1 for each experiment
One-sample t-test was used for comparison of each experimental
variant to control.
RESULTS
GSK3α/β Inhibition Upregulates
NMDAR-Dependent Arc Expression and
Alters Dendritic Spine Morphology
Although GSK3α and GSKβ play a vital role in the plasticity
of excitatory synapses (Peineau et al., 2007, 2009; Cymerman
et al., 2015), very few relevant effectors have been identified.
One important cellular function of GSK3α/β is to mark proteins
for degradation (Xu et al., 2009). Therefore, we examined
whether GSK3α/β inhibition affects the levels of Arc, a synaptic
plasticity protein with very fast turnover, the expression of
which is quickly terminated by the ubiquitin-proteasome system
(Rao et al., 2006; Greer et al., 2010; Soulé et al., 2012;
Bateup et al., 2013; Mabb et al., 2014). Arc protein levels in
unstimulated 15 day in vitro (DIV) cortical neurons were very
low and increased upon 4 h stimulation with 10 µM NMDA
(Figures 1A,B). This result was consistent with previous reports
that showed that NMDARs are crucial for the induction of
Arc expression in neurons (Lyford et al., 1995; Rao et al.,
2006; Bloomer et al., 2008; Kawashima et al., 2009; Panja
et al., 2009; Bateup et al., 2013). The adenosine triphosphate
(ATP)-competitive GSK3α/β inhibitors BIO and CH98 at
concentrations that efficiently blocked β-catenin degradation
(Figure 1C) augmented the effect of NMDA on Arc expression
(Figures 1A,B). GSK3α/β inhibition also promoted Arc protein
accumulation in hippocampal neurons that were stimulated with
NMDA, revealed by immunocytochemical staining. Arc resided
primarily in dendrites, but it was also localized to the cell
nucleus, especially in neurons with abundant Arc expression
(Figure 1D). The specificity of Arc IF was confirmed under
conditions of Arc knockdown (Figure 1E). Next, we investigated
whether GSK3α/β inhibition influences Arc mRNA levels in
NMDA-stimulated cortical neurons. We found no difference
between neurons that were exposed to NMDA alone and neurons
that were exposed to both NMDA and GSK3α/β inhibitors
(Figure 1F). Thus we concluded that GSK3α/β regulate Arc
protein expression upon NMDAR activation without affecting
Arc mRNA levels.
Arc overexpression results in a higher proportion of thin
dendritic spines and decrease in medium spine width (Peebles
et al., 2010). First, we investigated the effect of prolonged
NMDAR stimulation and GSK3α/β inhibition, shown above
to increase Arc expression, on dendritic protrusion width.
A tendency toward a decrease in protrusion width was
observed in cells that were treated with CH98 alone (4.3%
reduction). Treatment with BIO alone and NMDA alone
decreased protrusion width by 9.5% and 10.1%, respectively
(Figures 2A,B). When neurons were exposed to both NMDA
and CH98, a 21.7% reduction of protrusion width was observed
compared with vehicle-treated cells. The combination of BIO and
NMDA led to 30% decrease while comparing to control neurons.
These results demonstrate the synergistic actions of GSK3α/β
inhibitors and NMDA on average width of dendritic protrusion
(Figures 2A,B). Analysis of cumulative distribution of protrusion
width further confirmed their thinning Figure 2C). Next,
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FIGURE 1 | Glycogen synthase kinases α and β (GSK3α/β) inhibition increases Arc protein but not Arc mRNA levels in N-methyl-D-aspartate (NMDA)-stimulated
neurons. (A) NMDA receptors (NMDAR)-dependent increase in Arc protein levels is augmented by GSK3α/β inhibition. Western blot analysis of Arc and α-tubulin
expression in cortical neurons on day in vitro (DIV) 14–16 pretreated with vehicle, 1 µM CH98, or 1 µM BIO for 1 h and exposed for 4 h to 10 µM NMDA.
(B) Quantification of Arc protein expression in neurons treated as in (A), normalized to α-tubulin level. The data are expressed as mean ± standard error of the mean
(SEM; n = 6 independent cultures). ∗p < 0.05, ∗∗p < 0.01 indicates statistical significance of the obtained results, estimated with one-way ANOVA with Bonferroni
correction for multiple comparisons. (C) GSK3α/β inhibitors efficiently block β-catenin (i.e., the canonical target of GSK3α/β) degradation in neurons and promote its
nuclear accumulation. Representative confocal images of β-catenin immunofluorescence in hippocampal neurons that were incubated with vehicle, 1 µM CH98, or
1 µM BIO for 4 h, fixed, immunolabeled for β-catenin, and stained with DAPI to visualize chromatin. Scale bar = 25 µm. (D) GSK3α/β inhibition promotes Arc
accumulation in dendrites and nucleus of NMDA-stimulated neurons. The figure shows representative confocal images of Arc immunofluorescence in hippocampal
neurons that were pretreated with vehicle or 1 µM CH98 or 1 µM BIO for 1 h and treated with 10 µM NMDA for 4 h. Scale bar = 50 µm. (E) Arc knockdown
prevents NMDA and GSK3 inhibition-dependent
(Continued)
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FIGURE 1 | Continued
increase in Arc immunofluorescence. The figure shows representative confocal
images of Arc immunofluorescence in hippocampal neurons that were
transfected on DIV12–13 with control vector (pSuper) or the mix of pSuper
plasmids encoding shRNA against Arc mRNA together with β-actin-mCherry
plasmid to visualize transfected cells. Two days postransfection cells were
treated for 4 h as indicated. Scale bar = 25 µm. (F) GSK3α/β inhibition does
not affect NMDAR-dependent Arc mRNA expression. The figure shows the
results of the analysis of Arc mRNA levels in neurons that were stimulated with
NMDA and GSK3α/β inhibitors. Cortical neurons were pretreated with
GSK3α/β inhibitors, and Arc expression was induced with 10 µM NMDA for
2 h. Arc mRNA levels were determined by RT-qPCR, and the values were
compared with controls (Arc mRNA levels in vehicle-treated cells). The data
are expressed as mean ± SEM (n = 4 independent cultures). ∗p < 0.05
(one-way ANOVA with Bonferroni correction for multiple comparisons).
dendritic protrusions were classified as filopodia, mushroom,
stubby and thin spines, based on their width and morphology
(as described in ‘‘Materials and Methods’’ Section) and
the percentage of each protrusion type was calculated. The
concomitant inhibition of GSK3α/β and NMDAR stimulation
potently increased percentage of filopodia and reduced the
contribution of mushroom spines, while proportion of stubby
and thin spines didn’t vary significantly between conditions
(Figure 2D).
GSK3α/β Promote Arc Degradation in
NMDA-Treated Neurons
Multiple GSK3α/β-phosphorylated proteins are ubiquitinated
and subsequently directed to proteasomal degradation (Xu
et al., 2009). To investigate whether Arc protein stability is
regulated by GSK3α/β, cortical neurons were treated with
NMDA alone or in a combination with CH98 and then
exposed to the translation blocker anisomycin (Figure 3A). Arc
protein decay was slower upon GSK3α/β inhibition, indicating
that GSK3α/β control Arc protein stability in NMDA-treated
neurons (Figures 3B,C). A similar effect was observed when
protein synthesis was blocked with another translation inhibitor,
cycloheximide (Supplementary Figure S1).
Next, we sought to determine the lysine residue(s) of Arc
that were ubiquitinated in a GSK3α/β-dependent manner.
We performed mass spectrometry (MS) analysis of rat Arc
co-expressed in human embryonic kidney 293 (HEK293)
cells without and with the constitutively active form of
GSK3β (GSK3β S9A). Cells were treated for 1.5 h with the
proteasome inhibitor MG-132 to preserve ubiquitinated Arc
from proteasome-dependent degradation. MS identified Arc
lysine 136 (K136) as a residue that is ubiquitinated in a
GSK3β-dependent manner, in which the ubiquitination of
lysine 136 (K136) was detected only upon co-expression with
GSK3β S9A (Figure 3D). This ubiquitination appeared to be
conserved across species because the same modification was
identified in human Arc co-expressed with GSK3β S9A (data not
shown).
Subsequently, we evaluated the contribution of Arc
lysine 136 ubiquitination to Arc degradation. We employed
lentivirus-based synaptic activity-responsive element (SARE)-
Arc constructs, in which Arc expression is driven by the
SARE-ArcMin promoter (Kawashima et al., 2009; Figure 3E).
This allowed the construct to respond to neuronal stimulation
(e.g., NMDA treatment, Figure 3F). The Arc mutant in
which lysine 136 was substituted with arginine (Arc K136R)
decayed more slowly in NMDA-stimulated cortical neurons,
thus demonstrating the importance of the newly identified
ubiquitination site for Arc degradation (Figures 3F,G). To
further confirm that lysine 136 ubiquitination depends on
GSK3β, we compared the expression of wildtype SARE-Arc and
the K136R mutant upon NMDAR stimulation in neurons that
were co-transfected with an empty vector (β-actin-16pl) or with
the GSK3β S9A construct (Figures 3H,I). The overexpression of
constitutively active GSK3β prevented the NMDAR-dependent
increase in wildtype Arc but not Arc K136R mutant levels. These
results indicate that the ubiquitination of lysine 136 in Arc is
required for GSK3β-dependent Arc decay.
GSK3α/β-Mediated Arc Phosphorylation
Regulates its Stability
Arc in neurons is ubiquitinated and subsequently degraded in a
GSK3α/β-dependent manner. Therefore, we evaluated whether
GSK3α and GSK3β bind directly to and phosphorylate Arc
protein. GSK3β was pulled down on GST-tagged bacterially
expressed Arc (Figure 4A). Similarly, both human and rat Arc
protein that were overexpressed and isolated from HEK293 cells
were observed to bind GSK3α/β (Figure 4B). Within the cell,
active kinase and substrate form very transient complexes
prior to substrate phosphorylation (Belozerov et al., 2014).
We hypothesized that the binding of an enzymatically inactive
kinase mutant to Arc should be stronger than the binding of
wildtype kinase. Indeed, Arc bound enzymatically inactive forms
of GSK3α and GSK3β (K148A and K85A mutants, respectively)
more efficiently than wildtype enzymes (Figure 4C). These
findings suggested that indeed GSK3α/β might serve as an
Arc kinase. We then demonstrated this directly by performing
in vitro kinase assays and found that both GSK3β and GSK3α
phosphorylated rat and human Arc (Figures 4D,E). To identify
potential residues of Arc that are phosphorylated by GSK3α/β,
we utilized Group Based Predictor System v. 2.1 (GPS2.1), a
bioinformatic tool that allows the prediction of phosphorylation
sites for selected kinases in a given protein sequence (Xue et al.,
2011). The prediction returned five hits, including serines or
threonines followed by proline: serine 170, threonine 175, serine
S206, threonine 368 and threonine 380 (Figure 5A). Serine 170,
threonine 175, serine S206 and threonine 380 are conserved from
rat and mouse to human Arc protein (Figure 5B). The tandem
MS analysis of Arc overexpressed in HEK293 cells (pretreated
with CH98) and subsequently phosphorylated by GSK3β
in vitro, upon enrichment on titanium dioxide allowed the
identification of Arc-derived phosphopeptides that encompassed
serine 170, threonine 175, and threonine 380 (Figure 5C). It
should be noted however, that those sites were identified also
in Arc protein purified from HEK293 cells pretreated with
CH98 and not phosphorylated in vitro, inferring that these
sites could be phosphorylated by GSK3α/β and/or by other
kinases (e.g., as prephosphorylation sites for GSK3). Serine
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FIGURE 2 | Combined treatment with NMDA and GSK3α/β inhibitors (CH98, BIO) leads to dendritic protrusion thinning and alterations in dendritic spine
morphology. (A) Representative confocal images of dendritic protrusions. Hippocampal neurons were transfected with β-actin-GFP plasmid to visualize cell
morphology and stimulated with 10 µM NMDA with or without 1 µM CH98 or 1 µM BIO for 4 h. Scale bar = 5 µm. (B) Quantitative analysis of dendritic spine width.
Measurements were averaged per dendrite segment. Two dendrite segments per cell from 10 to 15 cells from two independent cultures were analyzed (5–8 cells per
culture). The data are expressed as mean protrusion width ± SEM. ∗∗p < 0.01, ∗∗∗p < 0.001 (one-way ANOVA with Bonferroni correction for multiple comparisons).
(C) Cumulative percentage plot of protrusion width for neurons from (B). Calculations were done for 522–680 spines per condition. (D) Analysis of dendritic
protrusion categories for neurons from (B). Categorization was done for dendrite segment and two dendrites per cell were analyzed. Data are expressed as mean
percentage of all protrusions ± SEM. ∗∗p < 0.01, ∗∗∗p < 0.001 (one-way ANOVA with Bonferroni correction for multiple comparisons).
206 has also been recently confirmed to be phosphorylated
by another kinase in vitro and in vivo (Nikolaienko et al.,
submitted).
To determine whether the predicted residues in Arc
protein are important for GSK3β-mediated phosphorylation,
we generated unphosphorylatable mutants of Arc by
substituting S170, T175, T368 and T380 with alanines and
performed an in vitro kinase assay. The levels of GSK3β-
mediated phosphorylation of the double Arc mutants
S170A/T175A and T368A/T380A were reduced by 45% and 43%,
respectively, compared with wildtype Arc phosphorylation. The
phosphorylation of the quadruple Arc mutant (later referred to as
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FIGURE 3 | GSK3α and GSK3β promote Arc protein degradation and ubiquitination. (A) Schematic representation of cell treatment. Cortical neurons were
pretreated with vehicle or 1 µM CH98 for 1 h, and then 10 µM NMDA was applied for 4 h. After this period, protein synthesis was inhibited with 40 µM anisomycin.
The cells were harvested at the times indicated. (B) GSK3α/β inhibition results in slower Arc degradation. The rate of Arc degradation was evaluated by Western blot.
(C) Quantification of Arc protein degradation rate in neurons treated as in (A). Arc expression level was first normalized to α-tubulin level. Next, relative decrease in
Arc expression was calculated as a ratio of Arc level at a given time point (45 or 90 min of anisomycin treatment) to Arc level at the “time 0”, when anisomycin was
added to neurons pretreated with NMDA or NMDA with 1 µM CH98. Decrease in Arc levels in NMDA and NMDA with GSK3α/β inhibitor-treated neurons was
compared separately for 45 or 90 min of anisomycin treatment and the difference was evaluated with t-test. The data are expressed as mean ± SEM
(n = 6 independent cultures). ∗p < 0.05, ∗∗p < 0.01. (D) A novel GSK3β-dependent ubiquitination site is present in Arc protein. The figure shows representative
fragmentation of a peptide that encompassed the ubiquitinated K136 residue, derived from rat Arc protein upon its co-expression with GSK3β S9A in HEK293 cells
and incubation with the proteasome inhibitor MG-132 (10 µM) for 1.5 h. (E) Schematic representation of SARE-Arc and SARE-mCherry cassettes. (F) Lysine
136 ubiquitination is important for Arc degradation in neurons. The figure shows the Western blot analysis of the levels of HA-tagged Arc that was overexpressed in
cortical neurons. Cells that were transduced with lentiviral vectors that carried wildtype SARE-Arc or SARE-Arc K136R were treated with vehicle or NMDA for 4 h.
Anisomycin was then added to the neurons that were treated with NMDA for the times indicated. (G) Quantification of Western blot results from (F). HA-tagged Arc
expression levels were first normalized to α-tubulin levels. Next, relative decrease in HA-Arc expression was calculated as a ratio of HA-Arc level at a given time point
(45 or 90 min of anisomycin treatment) to HA-Arc level at the “time 0”, when anisomycin was added to neurons pretreated with NMDA. Decrease in Arc and Arc
K136R levels was compared separately for 45 or 90 min of anisomycin treatment and the difference was evaluated with t-test. The data are expressed as
mean ± SEM (n = 5 independent cultures). ∗p < 0.05 (t-test). (H) K136R mutant of Arc is resistant to GSK3β-induced degradation. The figure shows representative
confocal images of HA-tagged Arc expression in hippocampal neurons. Images were transformed to “blue to yellow” pseudo color mode to visualize differences in
(Continued)
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FIGURE 3 | Continued
immunofluorescence intensity. Scale bar = 10 µm. Cells were co-transfected
with β-actin 16pl vector or GSK3β S9A and wildtype SARE-Arc or the K136R
mutant together with SARE-mCherry plasmid for 20 h and stimulated with
NMDA for 4 h. (I) Quantitative analysis of HA-tagged Arc expression. For each
cell, the HA immunofluorescence intensity was normalized to mCherry
fluorescence intensity. For each kind of transfection, the expression of
HA-tagged Arc in NMDA-stimulated cells was compared with its expression in
unstimulated cells. Immunofluorescence intensity was measured from 60 to
70 cells per condition, derived from three independent cultures. ∗∗∗p < 0.001;
ns, not significant (Mann-Whitney test).
4A) was 63% lower compared with wildtype Arc (Figures 6A,B).
The bioinformatic analysis of Arc sequence followed by
biochemical and biophysical characterization of Arc protein
FIGURE 4 | GSK3α/β binds and phosphorylates Arc protein. (A) GSK3β
directly associates with Arc protein. Purified GST-Arc protein of rat origin was
incubated with protein lysate from rat hippocampus. GSK3α/β binding was
determined by Western blot. (B) GSK3α/β may directly associate with Arc
protein in cells. Rat and human Arc or β-Gal proteins that were overexpressed
in HEK293 cells were captured on streptavidin-coated beads and incubated
with mouse hippocampal lysate. Bait-kinase binding was estimated by
probing the blot with anti-GSK3α/β antibody. Bait (e.g., biotinylated Arc or
β-Gal) was detected using fluorescently labeled streptavidin. (C) Kinase dead
(KD) mutants of GSK3α (K148A) and GSK3β (K85A) display greater affinity to
rat Arc protein than wildtype kinases. HA-tagged BIO- Arc protein was
overexpressed in HEK293 cells together with a wildtype or KD form of
FLAG-GSK3α (K148A) or a wildtype or KD form of FLAG-GSK3β (K85A) for
20 h. Cell lysates were then harvested and immediately subjected to avi-tag
co-precipitation. Blots were probed with anti-FLAG antibody to detect
overexpressed GSK3α/β proteins and probed with anti-HA antibody to detect
recombinant Arc. (D,E) Rat and human Arc proteins are phosphorylated
in vitro by recombinant GSK3α and GSK3β. The figures show representative
results from the in vitro kinase assay. Arc proteins that were overexpressed in
HEK293 cells were isolated and incubated with or without recombinant
GSK3α or GSK3β. Arc phosphorylation was detected by autoradiography. The
level of total Arc was estimated with Coomassie Brilliant Blue staining. The
phosphorylated GSK3β band is visible beneath the Arc band (indicated by
asterisk [∗]).
implied the presence of two protein domains with defined
structure (Myrum et al., 2015; Zhang et al., 2015), separated by
more disordered central region (Myrum et al., 2015). Putative
GSK3α/β-targeted residues S170 and T175 are localized to this
central disordered region of Arc, and T368 and T380 are part of
the putative PEST sequence (aa 351–392) that is located at the
Arc C-terminus (Rao et al., 2006; Figure 6C). We next employed
an anti-phospho S170/T175 Arc antibody to confirm the GSK3β-
mediated phosphorylation of these residues. The co-expression
of rat Arc together with GSK3β S9A and GSK3α S21A in
HEK293 cells potently increased S170/T175 phosphorylation
(Figures 6D,E). Anti-P-Arc antibody did not recognize Arc
when S170 is mutated to alanine, however single T175A mutant
is still recognized by anti-P-Arc antibody (Figure 6D). This
result suggests that both phosphorylated residues are detected by
anti-P-Arc antibody, although with slightly different efficiency
and in particular confirms that GSK3β targets S170 despite the
lack of detection of phosphorylated S170 by MS analysis. Arc
proteins of rat and human origin that were phosphorylated
in vitro by GSK3β (as in Figure 4D) presented a much higher
level of S170/T175 phosphorylation compared with control
conditions (i.e., incubation without kinase; Figure 6F).
Finally, we determined whether the identified GSK3β-
phosphorylated residues of Arc are important for protein
degradation in NMDA-stimulated neurons. We created a
lentiviral vector that carried the 4A mutant of SARE-Arc and
evaluated its rate of degradation compared with wildtype SARE-
Arc. NMDA-stimulated cortical neurons that were transduced
with wildtype SARE-Arc or SARE-Arc 4A were harvested at
time ‘‘0’’ or treated with anisomycin for 45 or 90 min. The
rate of Arc degradation was then evaluated by Western blot.
The Arc 4A mutant that was resistant to GSK3β-mediated
phosphorylation decayed much slower than wildtype protein
(Figures 7A,B), showing that phosphorylation by GSK3β
regulates Arc protein degradation in neurons. We then compared
the levels of the NMDAR-dependent induction of wildtype Arc
vs. Arc 4A expression in neurons that were co-transfected with
an empty vector (β-actin-16pl) or GSK3β S9A. The NMDAR-
dependent increase in wildtype Arc expression was abolished
by constitutively active GSK3β, whereas the expression of the
unphosphorylatable Arc mutant was unaffected (Figures 7C,D).
These results indicate that the identified residues within Arc are
critical for GSK3β-mediated Arc degradation.
GSK3α/β-Mediated Arc Protein
Degradation Contributes to the Structural
Plasticity of Dendritic Spines
As shown above, conditions that increased Arc expression and
stability (i.e., simultaneous treatment with NMDA and GSK3α/β
inhibitors) resulted in a reduction of dendritic protrusion
width and subsequent increase in a proportion of filopodia
and decreased percentage of mushroom spines (Figure 2).
The overexpression of wildtype Arc enhanced the NMDAR-
dependent decrease in protrusion width (Figures 8A,B).
Observed protrusion shrinkage was further augmented by
the introduction of ubiquitination-resistant (K136R) and
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FIGURE 5 | Potential GSK3 phosphorylation sites are present in Arc sequence. (A) Bioinformatic prediction of potential GSK3β phosphorylation sites in the rat Arc
sequence based on Group Based Predictor Phosphorylation System 2.1 (GPS 2.1). The potential GSK3β-targeted residues of Arc are listed in the table.
(B) Sequence alignment of human, rat, and mouse Arc amino acid sequences. Residues that are potentially targeted by GSK3β are marked with black boxes.
(C) Mass spectrometry (MS)/MS analysis indicates phosphorylated residues within Arc protein. The figure shows exemplary phosphopeptides that were identified by
phospho-MS analysis of rat Arc, overexpressed in HEK293 cells. Note the neutral loss (−98 Da) visible on threonine 175 (left panel) and threonine 380 (right panel),
indicating the phosphorylation of these residues in living cells.
unphosphorylatable (4A) mutants of Arc, both decreasing
protrusion width to the similar extent as observed in neurons
that were exposed to NMDA and CH98 (Figures 8A,B). Also
the cumulative distribution plot shows a similar shift toward
thinner protrusions in neurons transfected with Arc mutants
and mCherry transfected cells treated with NMDA and CH98
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FIGURE 6 | GSK3-dependent Arc phosphorylation requires presence of serine 170 and threonines 175, 368 and 380 of Arc. (A) Predicted and MS-indicated
residues of Arc required for GSK3-mediated phosphorylation in vitro, demonstrated by the in vitro kinase assay. The figure shows representative results of the in vitro
kinase assay. The S170, T175, T368 and T380 residues were substituted with alanines, and quadruple (all four residues mutated [4A]) or double (S170A/T175A and
T368A/T380A) mutants were subjected to in vitro phosphorylation by GSK3β, as indicated in the table below. (B) Quantitative analysis of kinase assay results. The
data represent the levels of Arc phosphorylation in the variants, where GSK3β was present. The optical density of the autoradiography bands was normalized to the
optical density of Coomassie Blue staining bands, and the obtained value for each mutant was compared with GSK3β-phosphorylated wildtype Arc levels. The data
are expressed as means ± SEM from three independent assays. ∗p < 0.05, ∗∗p < 0.01 (One sample t-test). (C) Schematic representation of Arc protein. Blue and
gray helices represent structured protein domains, the lines of red dots symbolize regions without defined secondary structure (disordered regions). Residues that are
critical for GSK3α/β-mediated phosphorylation are indicated with arrows. (D) GSK3β-mediated Arc phosphorylation at S170/T175 was confirmed with an antibody
that was developed against a peptide that encompassed phosphorylated S170 and T175 of Arc. The figure shows the Western blot analysis of phosphorylated Arc
expression. HEK293 cells were transfected with wildtype BIO-Arc together with pcDNA3 vector (pc) or wt BIO-Arc, S170A (S/A), T175A (T/A) or S170A/T175A
(ST/A) BIO-Arc together with FLAG GSK3β S9A. Twenty-four hours posttransfection, the cells were harvested, and Arc protein was isolated. Blots were probed with
anti-P-S170/T175 Arc antibody and rabbit anti-Arc antibody. Additionally, FLAG GSK3β S9A was detected in input fraction. Note the lack of a P-S170/T175 Arc
band in S170A and S170A/T175A mutant lanes and signal reduction in T175A lane. (E) GSK3α also upregulates phosphorylation of Arc S170/T175. The figure
shows the Western blot analysis of phosphorylated Arc expression. HEK293 cells were transfected with wildtype BIO-Arc together with pcDNA3 vector (pc) or
GSK3α S21A. Twenty-four hours posttransfection, the cells were harvested, and Arc protein was isolated. Blots were probed with anti-P-S170/T175 Arc antibody
and rabbit anti-Arc antibody. (F) Western blot showing rat and human Arc phosphorylation by GSK3β in the in vitro kinase assay. The assay was performed as in (B),
and the blot was probed with anti-P-S170/T175 Arc antibody and rabbit anti-Arc antibody.
(Figure 8C). Next, we determined how wildtype Arc or Arc
mutants affect distinct classes of dendritic protrusions. We found
decreased proportion of stubby spines and increased proportion
of thin spines in NMDA-treated neurons overexpressing
wildtype Arc while comparing to NMDA-treated cells transfected
with SARE-mCherry (Figure 8D). The comparison of dendritic
protrusions distribution in wildtype Arc overexpressing neurons
and neurons overexpressing ubiquitination-resistant (K136R)
and unphosphorylatable (4A) mutants of Arc treated with
NMDA revealed higher percentage of filopodia in neurons
transfected with 4A mutant of Arc and decreased percentage of
mushroom spines in cells overexpressing 4A and K136R Arc
mutants (Figure 8D). Functionally, the increase in Arc stability
translates into a more pronounced reduction of dendritic
protrusion width and promotes loss of mushroom spines. These
results underscore the importance of GSK3α/β-mediated Arc
decay for the structural plasticity of dendritic spines.
DISCUSSION
In the present study, we found that Arc, a protein that is
crucial for synaptic function, is phosphorylated and degraded in
a GSK3α/β-dependent manner upon prolonged NMDA receptor
stimulation. We further elucidated the effects of this degradation
on dendritic spine morphology.
GSK3α and GSK3β Phosphorylate Arc and
Direct it Toward Degradation
The present study provided evidence that GSK3α/β directly
phosphorylates Arc, resulting in its subsequent degradation.
Our findings demonstrate a novel role of Arc phosphorylation.
The mechanisms of Arc transcription and translation have
been studied quite intensively. Arc also undergoes variety
of posttranslational modifications, e.g., ubiquitination,
SUMOylation and phosphorylation. Thus far and as discussed
below, Arc ubiquitination was most extensively studied. Arc
mono-SUMOylation correlated with interaction of Arc with
drebrin A, an F-actin binding protein, during LTP consolidation
(Nair et al., 2017). The role of Arc phosphorylation, however,
has remained unknown.
Previous studies reported that Arc is phosphorylated at
threonine 278 and tyrosine 274, but the functions of these
modifications and respective kinases were not analyzed (Trinidad
et al., 2012; Palacios-Moreno et al., 2015). In this study, the
phosphorylation of two residues, namely T175 and T380 in
HEK 293 cells, was identified by MS (Figure 5C). However,
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FIGURE 7 | GSK3α/β-mediated phosphorylation leads to Arc degradation in neurons. (A) Quadruple (4A) mutant of Arc is more stable than wildtype protein in
NMDA-stimulated neurons. The figure shows the Western blot analysis of HA-tagged Arc overexpressed in cortical neurons. Cortical neurons were transduced with
lentiviral vectors that carried wildtype SARE-Arc or SARE-Arc4A. Twenty-one hours posttransduction, the cells were treated with NMDA for 4 h, and anisomycin was
added for the times indicated. (B) Quantification of Western blot results from (A). Next, relative decrease in HA-Arc expression was calculated as a ratio of HA-Arc
level at a given time point (45 or 90 min of anisomycin treatment) to HA-Arc level at the “time 0”, when anisomycin was added to neurons pretreated with NMDA.
Decrease in Arc and Arc 4A levels was compared separately for 45 or 90 min of anisomycin treatment and the difference was evaluated with t-test. The data are
expressed as mean ± SEM (n = 5 independent cultures). ∗p < 0.05, ∗∗p < 0.01 (t-test). (C) Unphosphorylatable mutant of Arc is insensitive to GSK3β- mediated
degradation. The figure shows representative confocal images of HA-tagged Arc expression in hippocampal neurons that were co-transfected with β-actin 16pl
vector or GSK3β S9A and wildtype SARE-Arc or the 4A mutant together with SARE-mCherry plasmid for 20 h and stimulated with NMDA for 4 h. Images were
transformed to “blue to yellow” pseudo color mode to visualize differences in immunofluorescence intensity. Scale bar = 10 µm. (D) Quantitative analysis of Arc
expression. HA immunofluorescence was measured and normalized to mCherry fluorescence. For each kind of transfection, the normalized expression of HA-tagged
Arc in NMDA-treated neurons was compared with Arc expression in control cells. Sixty to seventy cells per condition from three independent cultures were analyzed.
∗∗p < 0.01, ∗∗∗p < 0.001; ns, not significant (Mann-Whitney test).
bioinformatic analysis suggested existence of several more
phosphorylation sites in Arc, some of them being potential
GSK3α/β substrates (e.g., S170, T368; Figure 5A). Subsequent
experiments in HEK293 cells strongly suggested that Arc
S170 indeed can be also phosphorylated. But in vitro kinase
assays showed that only combined substitution of S170, T175,
T368 and T380 with alanines potently prevented GSK3β-
dependent Arc phosphorylation. Therefore 4A mutant was used
for subsequent functional studies. Nevertheless a question is
why S170 and T368 were not found by our MS analysis. It is
possible that phospho-MS analysis leaves some phosphorylated
residues undetected. In particular, peptides phosphorylated at
multiple residues located close to each other are difficult to
analyze (Dephoure et al., 2013). Also the efficiency of protease
cleavage and fragmentation into ions may vary depending on
structure and sequence of analyzed protein, and in turn influence
the identification of phosphorylated residues. So although
4A mutant was in our opinion most reasonable choice for
functional studies in neurons, further work will be required to
confirm, which of these four residues are actually bona fide
GSK3α/β substrates in neurons.
In contrast to Arc phosphorylation, the ubiquitination of Arc
has been studied in more detail. Two E3 ligases (Triad3A and
Ube3A) have been shown to ubiquitinate Arc at lysines 268 and
269 (Greer et al., 2010; Mabb et al., 2014). Lysine 136 in Arc was
also shown to be ubiquitinated by Triad3A in a cell-free assay.
However, the functional effect of this ubiquitination on Arc
stability was not confirmed or further evaluated in neuronal cells
because lysines 268 and 269 appeared to be solely responsible
for Arc ubiquitination and degradation (Mabb et al., 2014).
Mabb et al. (2014) found that the ubiquitination of lysines
268 and 269 was crucial for Arc degradation in neurons that were
stimulated with bicuculline and 4-aminopyridine. In the present
study, we showed in HEK293 cells using overexpressed Arc, that
its Lys136 is also ubiquitinated in vivo in a GSK3α/β-dependent
manner. Furthermore, we proved importance of Lys136 in Arc
degradation in neurons in the context of NMDAR stimulation,
which may have a different outcome with regard to the enzymatic
activity of GSK3α/β compared with the stimulation conditions
that were employed by Mabb et al. (2014). However, to
fully prove this hypothesis future research should provide an
evidence of GSK3α/β-dependent ubiquitination of Arc Lys136 in
Frontiers in Molecular Neuroscience | www.frontiersin.org 14 June 2017 | Volume 10 | Article 192
Gozdz et al. GSK3α/β Regulate Arc Protein Degradation
FIGURE 8 | The overexpression of K136R and 4A Arc mutants enhances reduction of dendritic protrusion width and alterations in dendritic spine morphology.
Hippocampal neurons were transfected with SARE-mCherry, wildtype SARE-Arc, SARE-Arc K136R, or SARE-Arc 4A together with β-actin-GFP to visualize cell
morphology and stimulated with 10 µM NMDA for 4 h. CH98 (1 µM) was added where indicated. (A) Representative images of GFP fluorescence in dendrite
fragments of neurons that were transfected and treated as indicated. Scale bar = 5 µm. (B) Quantitative analysis of dendritic protrusion width. Measurements were
averaged per dendrite segment. Two dendrite segments per cell from 20 to 27 cells from three independent cultures were analyzed (6–9 cells per culture). The data
are expressed as the mean protrusion width ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (one-way ANOVA with Bonferroni correction for multiple comparisons).
(C) Cumulative percentage plot of spine width for neurons from (B). Calculations were done for 1700–2000 protrusions per condition. (D) Analysis of dendritic
protrusion categories for neurons from (B). Categorization was done for dendrite segment. Two dendrites per cell were analyzed. Data are expressed as mean
percentage of protrusions ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (one-way ANOVA with Bonferroni correction for multiple comparisons).
neurons in response to different types of neuronal stimulation
including not only NMDA application but also more plasticity-
related situations, like LTP or LTD. Yet, due to technical
reasons, biochemical analysis of Arc ubiquitination proven to be
technically very challenging.
GSK3α/β plays a well-known role in the phosphorylation
of proteins that are destined for proteasomal degradation. To
date, however, there is no evidence that GSK3α/β substrates
can be subsequently ubiquitinated by the Arc E3 ubiquitin
ligases Triad3A and Ube3A. The best studied E3 ubiquitin
ligases that cooperate with GSK3α/β are β-Transducing repeat
containing E3 ubiquitin protein ligase (β-Trcp), which mediates
the ubiquitination of the canonical GSK3α/β target β-catenin
and F-box and WD repeat domain containing 7 (FBXW7)
protein family members, which direct multiple nuclear proteins
to the proteasome (Xu et al., 2009; Lau et al., 2012) or
regulate Rictor stability (Koo et al., 2015). In the case
of proteins that are phosphorylated prior to ubiquitination,
E3 ubiquitin ligase recognizes the phosphorylated amino acid
sequence within the targeted protein, referred to as ‘‘phospho-
degron’’ (Hunter, 2007). Analysis of Arc amino acid sequence
indicated that DSGXXS/T sequence, recognized by β-Trcp
upon phosphorylation of serine and threonine residues, is
absent from Arc protein. E3 ligases from the FBXW7 family
recognize the pS/pTP sequence that is also found in GSK3α/β-
phosphorylated Arc. The role of these E3 ligases in the GSK3α/β-
driven degradation of Arc needs to be investigated. Still, the
possible interplay between the GSK3α/β-mediated degradation
of Arc and Triad3A/Ube3A also cannot be excluded based
on our data. Alternatively, the contribution of another, yet
unidentified Arc E3 ubiquitin ligase should be considered.
Some E3 ubiquitin ligases cooperate with GSK3α/β, but their
target phospho-degrons are not known (Xu et al., 2009).
Finally, protein degradation can be mediated by different
E3 ubiquitin ligases in a cellular localization-dependent manner,
such as in the case of β-catenin degradation (e.g., β-Trcp and
TRIM33; Xue et al., 2015), and the same may apply to Arc
protein since it resides both in cytoplasm and cell nucleus
(Korb et al., 2013; Figures 1D,E). Interestingly, FBXW7 α
and γ isoforms operate in cell nucleus (Lau et al., 2012).
Therefore, they may be the candidate E3 ubiquitin ligases
regulating nuclear Arc level, putatively in GSK3-dependent
manner.
GSK3α/β-Mediated Phosphorylation and
Degradation of Arc Contributes to
Dendritic Spine Plasticity
We found that the GSK3α/β-controlled stability of Arc affects
dendritic spine morphology. The extended expression of Arc
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led to reduction of protrusion width, which is consistent with
previous reports (Peebles et al., 2010) and the postulated role
of Arc in the pruning of synapses (Okuno et al., 2012). The
enhancement of Arc expression in neurons was achieved by
the transient inhibition of GSK3α/β under conditions that
promoted de novo Arc synthesis (Figure 1). The analysis
of spine types distribution suggests that increased stability
of Arc, whether achieved by pharmacological inhibition of
GSK3α/β or mutation of residues responsible for GSK3α/β-
dependent Arc ubiquitination or phosphorylation, promotes loss
of mushroom spines (Figures 2D, 8D). Interestingly, whereas
the effect of unphosphorylatable (4A) mutant of Arc and
combined treatment with NMDA and CH98 on protrusion
width, percentage of mushroom spines and filopodia is very
much alike, K136R mutation of Arc affects protrusion width and
spine morphology to lesser extent. However, this effect seems
to be consistent with rate of Arc degradation upon different
manipulations, e.g., K136R mutation does not prevent Arc
degradation as efficiently as application of GSK3α/β inhibitor or
mutating residues phosphorylated by GSK3α/β (Figures 3, 7).
GSK3α/β was shown to regulate the structural plasticity of
dendritic spines under basal conditions and upon chemical LTD
induction. The persistent lack of GSK3β that was caused by
gene knockout resulted in a decrease in spine head volume
(Ochs et al., 2015) and a decrease in the spine length-to-
width ratio (Kondratiuk et al., 2017). In the present study,
5 h incubation with the GSK3α/β inhibitor CH98 caused a
tendency toward a reduction of spine width, while BIO reduced
width by 9.5% (Figure 2). Our previous work showed that
upon chemical LTD induction, GSK3α/β inhibition prevented
the plasticity-induced decrease in spine width (Cymerman
et al., 2015). In the present study, we found that GSK3α/β
inhibition potentiated spine head thinning that was caused by
prolonged NMDAR stimulation. GSK3α activity can promote
spine shrinkage during short-term NMDAR activation leading to
chemical LTD while GSK3α/β limit spine thinning when neurons
are exposed to long-term NMDAR stimulation. This observation
implies that GSK3α/β play a protective and homeostatic role
in neurons, preventing spine pruning in the case of neuronal
hyperexcitation (e.g., prolonged activation of NMDAR). In
summary, to date, Arc transcription, Arc mRNA transportation
and translation, and Arc protein localization have been shown
to depend on the level of neuronal activity. Our data identify
the novel mechanisms for curtailing Arc expression and
function mediated by GSK3α/β-catalyzed phosphorylation and
degradation.
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